Nurses Are Significant to Practice Implications for Enzalutamide Treatment in nmCRPC
April 20th 2021Data presented at the Oncology Nursing Society’s 46th Annual Congress reiterated positive results from the PROSPER trial with enzalutamide in the treatment of nonmetastatic castration-resistant prostate cancer and the key implications these have for nurses treating men with the disease moving forward.